Curcumol alleviates liver fibrosis through inducing autophagy and ferroptosis in hepatic stellate cells

FASEB J. 2022 Dec;36(12):e22665. doi: 10.1096/fj.202200933RR.

Abstract

To explore the effect of curcumol on autophagy and ferroptosis of hepatic stellate cells, and to clarify the molecular mechanism of its anti-hepatic fibrosis. In the present study, we report that curcumol promotes the death of activated HSCs and reduces the deposition of extracellular matrix. Interestingly, curcumol treatment can trigger ferroptosis to eliminate activated HSCs characterized by iron overload, lipid ROS accumulation, glutathione depletion, and lipid peroxidation. Curcumol promotes HSC autophagy, which may be the key mechanism for its induction of ferroptosis. It is worth noting that the upregulation of nuclear receptor coactivator 4 (NCOA4) may play a key molecular mechanism. NCOA4 mediates the release of iron ions and induces the occurrence of ferroptosis. Overall, curcumol promotes autophagy in hepatic stellate cells, mediates the degradation of NCOA4 and FTH1 complexes, releases iron ions, leads to iron overload, and induces ferroptosis, which may be an important mechanism for its anti-hepatic fibrosis effect.

Keywords: NCOA4; autophagy; curcumol; ferroptosis; hepatic fibrosis; therapeutic target.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autophagy
  • Ferroptosis*
  • Hepatic Stellate Cells / metabolism
  • Humans
  • Iron / metabolism
  • Iron Overload* / metabolism
  • Liver Cirrhosis / metabolism

Substances

  • curcumol
  • Iron